[How I treat and manage erectile dysfunction in diabetics].
Buvat
J
J
CETPARP, 3 rue Carolus, 59000 Lille.
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D048909:Diabetes Complications / Q000175:diagnosis* / Q000628:therapy*; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human